Advances & More News / Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D

For adults with type 2 diabetes and asthma, exacerbation rates are lower for those prescribed glucagon-like peptide-1 receptor (GLP-1R) agonists, according to a study recently published in the American Journal of Respiratory and Critical Care Medicine.

read more

University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new ... read more
Ground breaking new research is underway at the University of Surrey in collaboration with Columbia University ... read more
Some call it baby fat. But recent research has shown that adults have it too--which is ... read more
Gregory Ginsberg, a Penn Medicine doctor, is exploring a new frontier in the treatment of type ... read more